Correlation Between Dominari Holdings and Vor Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dominari Holdings and Vor Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dominari Holdings and Vor Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dominari Holdings and Vor Biopharma, you can compare the effects of market volatilities on Dominari Holdings and Vor Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dominari Holdings with a short position of Vor Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dominari Holdings and Vor Biopharma.

Diversification Opportunities for Dominari Holdings and Vor Biopharma

-0.57
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Dominari and Vor is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Dominari Holdings and Vor Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vor Biopharma and Dominari Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dominari Holdings are associated (or correlated) with Vor Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vor Biopharma has no effect on the direction of Dominari Holdings i.e., Dominari Holdings and Vor Biopharma go up and down completely randomly.

Pair Corralation between Dominari Holdings and Vor Biopharma

Given the investment horizon of 90 days Dominari Holdings is expected to under-perform the Vor Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Dominari Holdings is 1.72 times less risky than Vor Biopharma. The stock trades about -0.2 of its potential returns per unit of risk. The Vor Biopharma is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  76.00  in Vor Biopharma on September 25, 2024 and sell it today you would earn a total of  11.00  from holding Vor Biopharma or generate 14.47% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy98.44%
ValuesDaily Returns

Dominari Holdings  vs.  Vor Biopharma

 Performance 
       Timeline  
Dominari Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dominari Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's primary indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Vor Biopharma 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Vor Biopharma are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting basic indicators, Vor Biopharma reported solid returns over the last few months and may actually be approaching a breakup point.

Dominari Holdings and Vor Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dominari Holdings and Vor Biopharma

The main advantage of trading using opposite Dominari Holdings and Vor Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dominari Holdings position performs unexpectedly, Vor Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vor Biopharma will offset losses from the drop in Vor Biopharma's long position.
The idea behind Dominari Holdings and Vor Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance